Transforming the lives of patients everywhere.
We are committed to the patient experience by following the science to develop impactful and versatile treatment solutions for everyone. At HOTH, we stand by our mission to innovate today for a better tomorrow.
Learn more about our therapeutic areas and Early Access program opportunities.
If you have questions regarding our clinical trials, please contact us here.
Phase 2a Clinical Trial
Safety, preliminary efficacy and pharmacokinetics of Application of Topical HT-001 in Adult Subjects and Patients In EGFR Inhibitor Therapy.
Phase 1b Clinical Trial
Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis.